Search research articles
Contact Us
Filters
Showing results (241-250 of 261) with videos related to
Page
of 27
Sort By:
Physical Review Letters
|
August 27, 2020
New ^{13}C(α,n)^{16}O Cross Section with Implications for Neutrino Mixing and Geoneutrino Measurements
M Febbraro, R J deBoer, S D Pain, et al.
Cancer Discovery
|
May 25, 2016
Efficacy and Safety of Abemaciclib, an Inhibitor of CDK4 and CDK6, for Patients with Breast Cancer, Non-Small Cell Lung Cancer, and Other Solid Tumors
Amita Patnaik, Lee S Rosen, Sara M Tolaney, et al.
Physical Review Letters
|
September 10, 2016
Evidence for Gamow-Teller Decay of ^{78}Ni Core from Beta-Delayed Neutron Emission Studies
M Madurga, S V Paulauskas, R Grzywacz, et al.
Physical Review Letters
|
August 18, 2023
Rare ^{40}K Decay with Implications for Fundamental Physics and Geochronology
M Stukel, L Hariasz, P C F Di Stefano, et al.
Physical Review Letters
|
September 10, 2016
Decays of the Three Top Contributors to the Reactor ν[over ¯]_{e} High-Energy Spectrum, ^{92}Rb, ^{96gs}Y, and ^{142}Cs, Studied with Total Absorption Spectroscopy
B C Rasco, M Wolińska-Cichocka, A Fijałkowska, et al.
Obstetrics and Gynecology
|
May 14, 2026
Neurodevelopmental Pediatric Follow-Up After the Azithromycin Prevention in Labor Use Study
Manimaran Ramani, Waldemar A Carlo, Musaku Mwenechanya, et al.
Blood
|
January 25, 2020
Avadomide monotherapy in relapsed/refractory DLBCL: safety, efficacy, and a predictive gene classifier
Cecilia Carpio, Reda Bouabdallah, Loïc Ysebaert, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 28, 2019
First-in-Human, First-in-Class Phase I Trial of the Anti-CD47 Antibody Hu5F9-G4 in Patients With Advanced Cancers
Branimir I Sikic, Nehal Lakhani, Amita Patnaik, et al.
The Lancet. Oncology
|
June 18, 2021
Lenvatinib plus pembrolizumab in patients with either treatment-naive or previously treated metastatic renal cell carcinoma (Study 111/KEYNOTE-146): a phase 1b/2 study
Chung-Han Lee, Amishi Yogesh Shah, Drew Rasco, et al.
Journal for Immunotherapy of Cancer
|
February 15, 2019
Correction to: 33rd Annual Meeting & Pre-Conference Programs of the Society for Immunotherapy of Cancer (SITC 2018)
Sneha Berry, Nicolas Giraldo, Peter Nguyen, et al.
Page
of 27
Search research articles
Search
Showing results (241-250 of 261) with videos related to
Sort By:
Page
of 27
Physical Review Letters
|
August 27, 2020
New ^{13}C(α,n)^{16}O Cross Section with Implications for Neutrino Mixing and Geoneutrino Measurements
M Febbraro, R J deBoer, S D Pain, et al.
Cancer Discovery
|
May 25, 2016
Efficacy and Safety of Abemaciclib, an Inhibitor of CDK4 and CDK6, for Patients with Breast Cancer, Non-Small Cell Lung Cancer, and Other Solid Tumors
Amita Patnaik, Lee S Rosen, Sara M Tolaney, et al.
Physical Review Letters
|
September 10, 2016
Evidence for Gamow-Teller Decay of ^{78}Ni Core from Beta-Delayed Neutron Emission Studies
M Madurga, S V Paulauskas, R Grzywacz, et al.
Physical Review Letters
|
August 18, 2023
Rare ^{40}K Decay with Implications for Fundamental Physics and Geochronology
M Stukel, L Hariasz, P C F Di Stefano, et al.
Physical Review Letters
|
September 10, 2016
Decays of the Three Top Contributors to the Reactor ν[over ¯]_{e} High-Energy Spectrum, ^{92}Rb, ^{96gs}Y, and ^{142}Cs, Studied with Total Absorption Spectroscopy
B C Rasco, M Wolińska-Cichocka, A Fijałkowska, et al.
Obstetrics and Gynecology
|
May 14, 2026
Neurodevelopmental Pediatric Follow-Up After the Azithromycin Prevention in Labor Use Study
Manimaran Ramani, Waldemar A Carlo, Musaku Mwenechanya, et al.
Blood
|
January 25, 2020
Avadomide monotherapy in relapsed/refractory DLBCL: safety, efficacy, and a predictive gene classifier
Cecilia Carpio, Reda Bouabdallah, Loïc Ysebaert, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 28, 2019
First-in-Human, First-in-Class Phase I Trial of the Anti-CD47 Antibody Hu5F9-G4 in Patients With Advanced Cancers
Branimir I Sikic, Nehal Lakhani, Amita Patnaik, et al.
The Lancet. Oncology
|
June 18, 2021
Lenvatinib plus pembrolizumab in patients with either treatment-naive or previously treated metastatic renal cell carcinoma (Study 111/KEYNOTE-146): a phase 1b/2 study
Chung-Han Lee, Amishi Yogesh Shah, Drew Rasco, et al.
Journal for Immunotherapy of Cancer
|
February 15, 2019
Correction to: 33rd Annual Meeting & Pre-Conference Programs of the Society for Immunotherapy of Cancer (SITC 2018)
Sneha Berry, Nicolas Giraldo, Peter Nguyen, et al.
Page
of 27